Jul 29, 2025 · This JAMA Insights explores optimal strategies for managing the adverse effects associated with incretin-based medications for obesity, including semaglutide and tirzepatide.

Dec 2, 2025 · Tirzepatide (Zepbound) is a once-weekly weight loss injection. Clinical trials showed a 50-lb weight loss over 72 weeks. Learn about dosing, side effects, warnings, and who is …

May 19, 2025 · Tirzepatide treatment is changing how we support people with obesity and type 2 diabetes. This new drug uses receptor agonists. These help lower body weight and improve …

Jan 14, 2025 · Prescribing, reviewing and stopping tirzepatide NICE recommends tirzepatide as an option for weight management and it can be prescribed in primary care or a specialist …

Jul 3, 2024 · Purpose of Review The glucagon-like peptide 1 (GLP-1) receptor agonists (RAs) liraglutide and semaglutide, and the dual GLP-1/glucose-dependent insulinotropic polypeptide …

Jun 1, 2025 · Obesity and type 2 diabetes mellites (T2DM) are intertwined epidemics that continue to pose significant challenges to global public health. We aim to review the available …

May 28, 2023 · Learn about Tirzepatide benefits and side effects as treatment for obesity and type 2 diabetes for informed healthcare decisions.

Conclusions: Tirzepatide demonstrates superior efficacy in weight management compared to existing treatments, with an acceptable safety profile. Its dual agonist action offers a promising …

Jul 17, 2025 · Tian Q, Song Y, Deng Y and Lin S (2025) Ef cacy and safety of tirzepatide for fi weight loss in patients with obesity or type 2 diabetes: a systematic review and meta-analysis.

Obesity is chronic disease and causal precursor to myriad other conditions, includ-ing type 2 diabetes. In an earlier analysis of the SURMOUNT-1 trial, tirzepatide was shown to provide …